Back

Glucose-lowering drugs and heart failure.

31 August 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the European Association for the Study of Diabetes (EASD) Treatment Open Access ESC Congress 2019

About the speaker

Photo
Professor Petar Seferovic

Faculty of Medicine, University of Belgrade, Belgrade (Serbia)

4 More presentations in this session

Presentation thumbnail
What is new in 2019 Guidelines on Diabetes, Pre-diabetes and Cardiovascular Diseases
Professor F. Cosentino (Stockholm, SE)
Slides Video
Presentation thumbnail
Management of dyslipidaemias.
Doctor M. Lettino (Monza, IT)
Slides Video
Presentation thumbnail
New evidence from cardiovascular outcome trials.
Professor N. Marx (Aachen, DE)
Slides Video
Presentation thumbnail
Benefits and risks of antithrombotic therapy in diabetes.
Professor B. Rocca (Casamassima, IT)
Slides Video

Access the full session

Session thumbnail
2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the European Association for the Study of Diabetes (EASD)

The Event

Event poster

ESC Congress 2019

31 August - 4 September 2019
You may be interested in
thumbnail
Congress Presentation
Treating heart failure in adult congenital heart disease: A-Z
thumbnail
Congress Presentation
How can we increase adherence to medical treatment in heart failure patients? A questionnaire study
thumbnail
Congress Presentation
Audience Q&A

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources